Tirzepatide is a dual receptor agonist. It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes. Tirzepatide does not currently have an FDA designation for weight loss and therefor is being used “off label”.Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist approved by the FDA in 2023 for chronic weight management. Clinical evidence shows tirzepatide can be highly effective for chronic weight loss when used long-term, especially at higher doses, though diet and exercise are still recommended for best results.For people with Type 2 diabetes and those with elevated body mass indexes or BMI, Mounjaro (Tirzepatide) is a “game changer.”
Wegovy and Ozempic activate the GLP-1 receptor ONLY while Mounjaro activates two receptors: both GLP-1 and GIP.These hormones control blood sugar levels, curb cravings,reduce appetite,increase satiety thereby triggering weight loss. In clinical trials,the average weight loss with Mounjaro resulted in patients losing 12 pounds more on average than those who used SemaglutideBoth Mounjaro & Zepbound include the same active ingredient Terzipatide.However,Zepbound is FDA approved for weight loss,Mounjaro for Diabetes
Mounjaro and Zepbound are two brand names for the drug tirzepatide.
Why choose Mounjaro for your weight loss?
Mounjaro has been proven to be effective in helping people lose weight.
Mounjaro can reduce appetite and cravings for unhealthy foods.
Mounjaro can boost metabolism and promote fat loss.
Mounjaro is convenient and easy to incorporate into your routine.
Mounjaro you are ready to take control of your weight and improve your overall health, Mounjaro may be the right choice for you.
One of the key benefits of Mounjaro is that it can help to reduce appetite and cravings for unhealthy foods. By activating the GLP-1 hormone, Mounjaro can signal to the brain that the body is full, helping to reduce the desire to overeat. It can also increase feelings of fullness after a meal, which can help to reduce the overall amount of food consumed.
In addition to its appetite-suppressing effects, Mounjaro has also been shown to boost metabolism and promote fat loss. By activating GLP-1, it can stimulate the body to burn fat for energy, rather than storing it. This can help to accelerate weight loss and improve overall health.
Why does Tirzepatide cause more weightloss than other Medications?
How much do I pay if my Insurance covers the medication?
You would pay only your Copay (or deductible) if your Insurance covers the Medication.
What if I don’t know what plan I need?
Our specialist can help you assess your particular issue and define which plan suits you the most. Feel free to contact us.
Mounjaro ( active ingredient is Tirzepatide )
It is a dual-action GLP-1/GIP agonist FDA approved for Type 2 diabetes but often used "off-label" for Weightloss. In clinical trials,people have lost an average of 20% of their body weight. will manage insurance pre-approvals or offer comparable, lower cost medication if not covered by insurance.or suggesting alternative treatments tailored to your unique health background.
With Insurance
Mounjaro ( Tirzepatide)
Tirzepatide is the generic and Mounjaro is a brand-name version.
FDA approved in 2022 for Diabetes but also causes Weight loss in people using it.Unlike Semaglutide, (the drug in Ozempic and Wegovy) which activates only one receptor (GLP 1 only) and therefore,is a "single-receptor agonist", Mounjaro activates receptors of two hormones (GLP1 and GIP) at the same time,"dual-agonist" This double agonist approach helps people who use Mounjaro to lower blood sugar and lose more weight than those who use a single-agonist medication like Wegovy. Wegovy and Ozempic activate the GLP-1 receptor ONLY while Mounjaro activates two receptors: both GLP-1 and GIP.These hormones control blood sugar levels, curb cravings,reduce appetite,increase satiety thereby triggering weight loss. In clinical trials,the average weight loss with Mounjaro resulted in patients losing 12 pounds more on average than those who used Semaglutide.
Read more